Abstract:Neuroinflammation is considered a balanced inflammatory response important in the intrinsic repair process after injury or infection. Under chronic states of disease, injury, or infection, persistent neuroinflammation results in a heightened presence of cytokines, chemokines, and reactive oxygen species that result in tissue damage. In the CNS, the surrounding microglia normally contain macrophages and other innate immune cells that perform active immune surveillance. The resulting cytokines produced by these macrophages affect the growth, development, and responsiveness of the microglia present in both white and gray matter regions of the CNS. Controlling the levels of these cytokines ultimately improves neurocognitive function and results in the repair of lesions associated with neurologic disease. MicroRNAs (miRNAs) are master regulators of the genome and subsequently control the activity of inflammatory responses crucial in sustaining a robust and acute immunological response towards an acute infection while dampening pathways that result in heightened levels of cytokines and chemokines associated with chronic neuroinflammation. Numerous reports have directly implicated miRNAs in controlling the abundance and activity of interleukins, TGF-B, NF-kB, and toll-like receptor-signaling intrinsically linked with the development of neurological disorders such as Parkinson’s, ALS, epilepsy, Alzheimer’s, and neuromuscular degeneration. This review is focused on discussing the role miRNAs play in regulating or initiating these chronic neurological states, many of which maintain the level and/or activity of neuron-specific secondary messengers. Dysregulated miRNAs present in the microglia, astrocytes, oligodendrocytes, and epididymal cells, contribute to an overall glial-specific inflammatory niche that impacts the activity of neuronal conductivity, signaling action potentials, neurotransmitter robustness, neuron-neuron specific communication, and neuron-muscular connections. Understanding which miRNAs regulate microglial activation is a crucial step forward in developing non-coding RNA-based therapeutics to treat and potentially correct the behavioral and cognitive deficits typically found in patients suffering from chronic neuroinflammation.

Th17 cells and inflammation in neurological disorders: Possible mechanisms of action

Interleukin-17A: the Key Cytokine in Neurodegenerative Diseases

Research progress on the role and regulatory mechanism of pathogenic Th17 cells in neuroinflammation

The role of Th17 cells/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A

CNS and CNS Diseases in Relation to Their Immune System

The potential for treg-enhancing therapies in nervous system pathologies

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Non-coding RNAs and neuroinflammation: implications for neurological disorders

Advances in the study of IL-17 in neurological diseases and mental disorders

Emerging Roles of T Helper Cells in Non-Infectious Neuroinflammation: Savior or Sinner

Interleukin-17 Promotes the Infiltration of CD8+ T Cells into the Brain in a Mouse Model for Alzheimer’s Disease

Inflammasomes in neurological disorders — mechanisms and therapeutic potential

Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update

T cells in the brain inflammation

The Role of T-lymphocytes in Central Nervous System Diseases

Roles Of T Helper 17 Cells And Interleukin-17 In Neuroautoimmune Diseases With Emphasis On Multiple Sclerosis And Guillain-Barre Syndrome As Well As Their Animal Models

Neuroinflammatory Responses and Parkinson' Disease: Pathogenic Mechanisms and Therapeutic Targets

Advances in gene therapy approaches targeting neuro-inflammation in neurodegenerative diseases

Targeting NLRP3 inflammasome for neurodegenerative disorders

The modulatory role of dopamine receptors in brain neuroinflammation

Targeting neuroinflammation in Alzheimer's disease: from mechanisms to clinical applications